Covered recipient · General Payments record
GUNJAN NIGAM
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,364.45
- Reported across 229 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $873.00 | 53 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $289.80 | 18 |
| Novo Nordisk AS | $158.27 | 13 |
| ABBVIE INC. | $156.10 | 8 |
| Lilly USA, LLC | $66.18 | 4 |
| Abbott Laboratories | $59.97 | 2 |
| Medtronic, Inc. | $23.88 | 1 |
| Merck Sharp & Dohme Corporation | $20.33 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19.38 | 1 |
| EISAI INC. | $17.69 | 1 |
| Acerta Pharma LLC | $16.40 | 1 |
| ORGANOGENESIS INC. | $15.91 | 1 |
| Phadia US Inc. | $14.72 | 1 |
| DEXCOM, INC. | $14.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (53)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $33.63 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124912906 | CMS |
| Abbott Laboratories | $26.34 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124912908 | CMS |
| ABBVIE INC. | $24.94 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105127177 | CMS |
| ABBVIE INC. | $29.93 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105127179 | CMS |
| ABBVIE INC. | $9.28 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105127181 | CMS |
| ABBVIE INC. | $2.00 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105127183 | CMS |
| ABBVIE INC. | $27.65 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105127185 | CMS |
| ABBVIE INC. | $18.41 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105127187 | CMS |
| ABBVIE INC. | $21.76 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105127189 | CMS |
| ABBVIE INC. | $22.13 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105127191 | CMS |
| Amgen Inc. | $5.74 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117340343 | CMS |
| Amgen Inc. | $5.49 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117340345 | CMS |
| Amgen Inc. | $5.14 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117340347 | CMS |
| Amgen Inc. | $4.83 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117340349 | CMS |
| Amgen Inc. | $6.24 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117340351 | CMS |
| Amgen Inc. | $15.03 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117340353 | CMS |
| Amgen Inc. | $6.18 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117340355 | CMS |
| Amgen Inc. | $6.78 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117340357 | CMS |
| Amgen Inc. | $6.52 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111662759 | CMS |
| Amgen Inc. | $150.00 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117340371 | CMS |
| Amgen Inc. | $5.90 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117340359 | CMS |
| Amgen Inc. | $6.73 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117340361 | CMS |
| Amgen Inc. | $7.07 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117340363 | CMS |
| Amgen Inc. | $6.64 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117340365 | CMS |
| Amgen Inc. | $5.90 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117340367 | CMS |
| Amgen Inc. | $13.28 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117340369 | CMS |
| Amgen Inc. | $15.09 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111662761 | CMS |
| Amgen Inc. | $17.24 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111662763 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.40 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105374417 | CMS |
| Dexcom, Inc. | $14.37 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153302537 | CMS |
| Eisai Inc. | $17.69 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110747598 | CMS |
| Lilly USA, LLC | $14.58 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135009919 | CMS |
| Lilly USA, LLC | $17.33 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135016900 | CMS |
| Lilly USA, LLC | $16.01 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134992372 | CMS |
| Lilly USA, LLC | $18.26 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135009917 | CMS |
| Medtronic, Inc. | $23.88 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117120485 | CMS |
| Merck Sharp & Dohme LLC | $20.33 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141963995 | CMS |
| Novo Nordisk Inc | $19.61 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096709064 | CMS |
| Novo Nordisk Inc | $5.37 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097379613 | CMS |
| Novo Nordisk Inc | $13.44 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097090469 | CMS |
| Novo Nordisk Inc | $1.28 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097159587 | CMS |
| Novo Nordisk Inc | $18.44 | 03/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097224057 | CMS |
| Novo Nordisk Inc | $15.20 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096925828 | CMS |
| Novo Nordisk Inc | $5.23 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096896451 | CMS |
| Novo Nordisk Inc | $1.20 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096712555 | CMS |
| Novo Nordisk Inc | $13.20 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097179107 | CMS |
| Novo Nordisk Inc | $18.02 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097598307 | CMS |
| Novo Nordisk Inc | $23.66 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097702130 | CMS |
| Novo Nordisk Inc | $12.04 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097805465 | CMS |
| Novo Nordisk Inc | $11.58 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096945987 | CMS |
| Organogenesis Inc. | $15.91 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145441189 | CMS |
| Phadia US Inc. | $14.72 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067579232 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19.38 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153538148 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.